OncoSpherix, Inc.
Atlanta, GA · Biotech · Private
64B, a small molecule HIF-1 inhibitor therapeutic for metastatic and high-risk uveal melanoma
oncospherix.com →- Grants
- $2.4M
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 3
- 0 granted · 3 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20202021202220232024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Arylsulfonamides for the Treatment of Primary and Metastatic Uveal Melanoma | $399,774 | |
| Federal grant | Department of Health and Human Services · Phase II · Arylsulfonamides for the Treatment of Primary and Metastatic Uveal Melanoma | $1,024,999 | |
| Federal grant | Department of Health and Human Services · Phase II · Arylsulfonamides for the Treatment of Primary and Metastatic Uveal Melanoma | $1,025,001 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1654 | Doric Pharma | — | — |
| 1655 | AGENOVIR CORPORATION | — | — |
| 1656 | FOR-ROBIN, INC. | — | — |
| 1657 | OncoSpherix, Inc. | — | — |
| 1658 | PHAGE REFINERY, INC. | — | — |
| 1659 | JUVENA THERAPEUTICS INC | — | — |
| 1660 | ISOTHERAPEUTICS GROUP, LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Solid Forms Of An Inhibitor Of Hif And Methods Of Using Sameapplication
- Solid Forms Of An Inhibitor Of Hif And Methods Of Using Sameapplication
- Solid Forms Of An Inhibitor Of Hif And Methods Of Using Sameapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.